[Practical Update of Total Dose Compensation in Case of Temporary Interruption of External Radiotherapy in the COVID-19 Pandemic Context]

Overview

Journal Cancer Radiother

Publisher Elsevier

Specialty Oncology

Date 2020 Apr 21

PMID 32307313

Citations 2

Authors

D Azria

C Hennequin

P Giraud

Affiliations

Soon will be listed here.

Abstract

Overall treatment time is an important factor of local recurrence and indirectly of distant evolution, namely in case of protracted treatments. The current pandemic impacts on the duration of radiotherapy if patients under treatments and synchronously suffering from COVID-19. The models used to compensate the total dose in case of temporary treatment interruption are well known but it is of importance in that pandemic context to update and homogenize clinical practice in order to improve local control without increasing normal tissue complications.

Citing Articles

Acute skin toxicity of ultra-hypofractionated whole breast radiotherapy with simultaneous integrated boost for early breast cancer.

Montero A, Ciervide R, Canadillas C, Alvarez B, Garcia-Aranda M, Alonso R Clin Transl Radiat Oncol. 2023; 41:100651.

PMID: 37388711 PMC: 10300060. DOI: 10.1016/j.ctro.2023.100651.

Radiation Therapy Department Reorganization during the Coronavirus Disease 2019 (COVID-19) Outbreak: Keys to Securing Staff and Patients During the First Weeks of the Crisis and Impact on Radiation Therapy Practice from a Single Institution....

Belkacemi Y, Loaganadane G, Grellier N, Fonteneau G, Zaoui G, Coraggio G Adv Radiat Oncol. 2020; 5(4):644-650.

PMID: 32775775 PMC: 7250781. DOI: 10.1016/j.adro.2020.04.039.

References

Gonzalez Ferreira J, Jaen Olasolo J, Azinovic I, Jeremic B . Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literature. Rep Pract Oncol Radiother. 2015; 20(5):328-39. PMC: 4597087. DOI: 10.1016/j.rpor.2015.05.010. View

Slevin N, Hendry J, Roberts S . The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapy. Radiother Oncol. 1992; 24(4):215-20. DOI: 10.1016/0167-8140(92)90226-k. View

Topkan E, Ozdemir Y, Kucuk A, Besen A, Mertsoylu H, Sezer A . Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patients. PLoS One. 2019; 14(7):e0218627. PMC: 6645460. DOI: 10.1371/journal.pone.0218627. View

Thames H, Kuban D, Levy L, Horwitz E, Kupelian P, Martinez A . The role of overall treatment time in the outcome of radiotherapy of prostate cancer: an analysis of biochemical failure in 4839 men treated between 1987 and 1995. Radiother Oncol. 2010; 96(1):6-12. DOI: 10.1016/j.radonc.2010.03.020. View

Dong Y, Zaorsky N, Li T, Churilla T, Viterbo R, Sobczak M . Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. J Med Imaging Radiat Oncol. 2017; 62(1):116-121. PMC: 5800942. DOI: 10.1111/1754-9485.12675. View

Klement R, Sonke J, Allgauer M, Andratschke N, Appold S, Belderbos J . Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy. Radiother Oncol. 2019; 142:210-216. DOI: 10.1016/j.radonc.2019.07.008. View

Harris E, Christensen V, Hwang W, Fox K, Solin L . Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol. 2004; 23(1):11-6. DOI: 10.1200/JCO.2005.09.056. View

Zheleva V, Nelson R, Dumitra S, Vora N, Lai L . Time to Adjuvant Radiotherapy in Breast Cancer Affects Survival: Implications for the American College of Surgeons Commission on Cancer Quality Metrics. Ann Surg Oncol. 2020; 27(8):2614-2625. DOI: 10.1245/s10434-020-08326-8. View

van Leeuwen C, Oei A, Crezee J, Bel A, Franken N, Stalpers L . The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studies. Radiat Oncol. 2018; 13(1):96. PMC: 5956964. DOI: 10.1186/s13014-018-1040-z. View

10.

Nix M, Rowbottom C, Vivekanandan S, Hawkins M, Fenwick J . Chemoradiotherapy of locally-advanced non-small cell lung cancer: Analysis of radiation dose-response, chemotherapy and survival-limiting toxicity effects indicates a low α/β ratio. Radiother Oncol. 2019; 143:58-65. DOI: 10.1016/j.radonc.2019.07.026. View

11.

Azria D, Belkacemi Y, Romieu G, Gourgou S, Gutowski M, Zaman K . Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial. Lancet Oncol. 2010; 11(3):258-65. DOI: 10.1016/S1470-2045(10)70013-9. View

12.

Mahe M, Barillot I, Chauvet B . [Guidelines for external radiotherapy and brachytherapy: 2nd edition]. Cancer Radiother. 2016; 20 Suppl:S4-7. DOI: 10.1016/j.canrad.2016.07.014. View

13.

King C . What is the T(pot) for prostate cancer? Radiobiological implications of the equivalent outcome with (125)I or (103)Pd. Int J Radiat Oncol Biol Phys. 2000; 47(5):1165-7. DOI: 10.1016/s0360-3016(00)00543-5. View

14.

Dale R, Jones B, Sinclair J . Dose equivalents of tumour repopulation during radiotherapy: the potential for confusion. Br J Radiol. 2000; 73(872):892-4. DOI: 10.1259/bjr.73.872.11026867. View

15.

Hong J, Foote J, Broadwater G, Sosa J, Gaillard S, Havrilesky L . Data-Derived Treatment Duration Goal for Cervical Cancer: Should 8 Weeks Remain the Target in the Era of Concurrent Chemoradiation?. JCO Clin Cancer Inform. 2019; 1:1-15. DOI: 10.1200/CCI.16.00072. View

16.

Machtay M, Hsu C, Komaki R, Sause W, Swann R, Langer C . Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non-small-cell lung carcinoma: analysis of the Radiation Therapy Oncology Group (RTOG) experience. Int J Radiat Oncol Biol Phys. 2005; 63(3):667-71. DOI: 10.1016/j.ijrobp.2005.03.037. View

17.

Bourgier C, Lacombe J, Solassol J, Mange A, Pelegrin A, Ozsahin M . Late side-effects after curative intent radiotherapy: Identification of hypersensitive patients for personalized strategy. Crit Rev Oncol Hematol. 2014; 93(3):312-9. DOI: 10.1016/j.critrevonc.2014.11.004. View

18.

Bese N, Hendry J, Jeremic B . Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation. Int J Radiat Oncol Biol Phys. 2007; 68(3):654-61. DOI: 10.1016/j.ijrobp.2007.03.010. View

19.

Qi X, White J, Li X . Is α/β for breast cancer really low?. Radiother Oncol. 2011; 100(2):282-8. DOI: 10.1016/j.radonc.2011.01.010. View

20.

Fowler J, Chappell R . Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys. 2000; 46(2):516-7. DOI: 10.1016/s0360-3016(99)00364-8. View